Mayo Clinic Tests First Stem Cell Heart Treatment

NH_FB_new-logo-ApprovedThe Mayo Clinic has launched the nation’s first stem cell clinical trial for pediatric congenital heart disease.

The trial is designed to determine whether stem cells taken from umbilical cord blood can help children with a rare defect — hypoplastic left heart syndrome (HLHS) — in which the left side of the organ is critically underdeveloped.

“We want to see if these stem cells will increase the volume and strength of the heart muscle to give it greater durability and power to pump blood throughout the body,” said Harold Burkhart, M.D., a pediatric cardiovascular surgeon with the Mayo Clinic Children’s Center.

The trial, which will include 10 infants with HLHS, aims to test the safety and feasibility of delivering a personalized stem cell-based therapy to children affected by the disorder.

The full article is located at Newsmax Health

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s